Abstract:Atrial natriuretic peptide (ANP), a small peptide consisting of 28 amino acids, has been applied in clinical treatment for heart failure, but it can encounter proteolytic degradation during its expression in host cells. Therefore, it is usually reported that ANP was expressed as a part of fusion protein. The aim of our study was to use an overexpression system to express the fusion protein REF-ANP and to optimize a purification method. First, Escherichia coli DH5alpha was transformed with constructed expression vector containing two tandem copies of ref-anp gene and the fusion protein REF-ANP was overexpressed in shaking flask culture. Subsequently, the inclusion bodies were purified with reverse phase chromatography and pooled fractions were lyophilized. After this step, REF-ANP can be solubilized under native conditions without urea. After cleavage reaction, the sample was subjected to size exclusion chromatography and then rANP was polished with reverse phase chromatography. The final purity of rANP was more than 98% and the recovery of rANP per liter of shaking flask culture was more than 3mg. Such methods as mass spectrometry, capillary isoelectrofocusing analysis, and N-terminal amino acid sequence were used to identify rANP. The capillary isoelectrofocusing analysis showed that the pI of ANP was about pH 9.7. In this study, an efficient refolding and purification process should make scaling-up procedures easier and more successful than earlier reports. Moreover, it is possible that the refolding and purification method along with the overexpression system described in this article may offer new ideas on optimizing expression and purification of other kinds of short peptides.

Expression and Purification of Soluble Human Neutrophil Gelatinase Associated Lipocalin in E.coli

High-efficiency Secretory Expression of Human Neutrophil Gelatinase-Associated Lipocalin from Mammalian Cell Lines with Human Serum Albumin Signal Peptide.

Construction of Recombinant NNMT Plasmid and Expression in E. Coli

Preparation of monoclonal antibodies against neutrophil gelatinase-associated lipocalin (NGAL) and development of an antibody-based chemiluminescence immune quantification assay

Prokaryotic expression and preparation of polyclonal antibody of NGAL

High efficiency expression and purification of lipopolysaccharide respond gene fusion protein

Expression and Purification of Angiogenin-Egfp Fusion Protein in E.coli

Prokaryotic Expression Purification and Identification of Human Amino-Terminal Pro-Brain Natriuretic Peptide and Its Stability

Expression of human NGFβ gene segment encoding mature peptide in E.coli and determination of its bioactivity

Overexpression and Purification of Recombinant Atrial Natriuretic Peptide Using Hybrid Fusion Protein REF-ANP in Escherichia Coli

Highly Efficient Expression and Purification of Human HMGB1 Gene in E.coli

Fermentation of Preparation of Recombinant Human Granulysin in Escherichia coli

Renaturing and Antigenic Identification of Human EGF Receptor Extracellular Domain Inclusion Body Overexpressed in Escherichia Coli

Expression of Gene Recombinant GLP-1 Derived Polypeptide and Its Purification and Identification

Expression, Purification and Bioactivity Analysis of Granulysin

Cloning of Human NKp46 Gene and Its Expression and Purification in E.coli

Construction of recombinant expression vector of granulysin gene and its prokaryotic expression

Optimization of Expression Conditions and Purification for GST-LRF Fusion Protein in E.coli

Optimized soluble expression and purification of an aggregation-prone protein by fusion tag systems and on-column cleavage in Escherichia coli.

Expression and purification of a novel therapeutic single-chain variable fragment antibody against BNP from inclusion bodies of Escherichia coli

Expression and Purification of Neutrophil Inhibitory Factor in E.coli